DNA Methylation Status of NKX2-5, GATA4 and HAND1in Patients with Tetralogy of Fallot

Wei Sheng,Yanyan Qian,Huijun Wang,Xiaojing Ma,Ping Zhang,Lianwei Diao,Quan An,Long Chen,Duan Ma,Guoying Huang

DOI: https://doi.org/10.1186/1755-8794-6-46

2013-01-01

BMC Medical Genomics

Abstract:NKX2-5, GATA4 and HAND1 are essential for heart development, however, little is known regarding their epigenetic regulation in the pathogenesis of tetralogy of fallot (TOF).

What problem does this paper attempt to address?

NEXN Inhibits GATA4 and Leads to Atrial Septal Defects in Mice and Humans

Fan Yang,Lei Zhou,Qiguang Wang,Xin You,Ying Li,Yong Zhao,Xiaonan Han,Zai Chang,Xin He,Chunyan Cheng,Chong Wu,Wen-Jing Wang,Fang-Yuan Hu,Ting Zhao,Yang Li,Ming Zhao,Gu-Yan Zheng,Jie Dong,Chun Fan,Juxian Yang,Xianmin Meng,Youyi Zhang,Xianyang Zhu,Jingwei Xiong,Xiao-Li Tian,Huiqing Cao

DOI: https://doi.org/10.1093/cvr/cvu134

IF: 13.081

2014-01-01

Cardiovascular Research

Abstract:Aims Cardiac structural genes have been implicated as causative factors for congenital heart diseases (CHDs). NEXN is an F-actin binding protein and previously identified as a disease gene causing cardiomyopathies. Whether NEXN contributes to CHDs aetiologically remains unknown. Here, we explored the function of NEXN in cardiac development.Methods and results First, we determine the role of NEXN in cardiac differentiation using mouse P19cl6 in vitro model; we demonstrated that NEXN inhibited cardiac contractile markers, serving as a negative regulator. Interestingly, we found this effect was mediated by GATA4, a crucial transcription factor that controls cardiac development by knockdown, overexpression, and rescue experiment, respectively. We then generated transgenic mouse models and surprisingly, we discovered cardiac-selective expression of the NEXN gene caused atrial septal defects (ASDs). Next, to search for the mutations in NEXN gene in patients suffering from ASDs, we sequenced the exon and exon-intron joint regions of the NEXN gene in 150 probands with isolated ASDs and identified three mutations in the conserved region of NEXN (c.-52-78C>A, K199E, and L227S), which were not found in 500 healthy controls. Finally, we characterize the related mechanisms and found all mutations inhibited GATA4 expression.Conclusion We identify NEXN as a novel gene for ASD and its function to inhibit GATA4 established a critical regulation of an F-actin binding protein on a transcription factor in cardiac development.
CpG Site Hypomethylation at ETS1‑binding Region Regulates DLK1 Expression in Chinese Patients with Tetralogy of Fallot.

Guixiang Tian,Lili He,Ruoyi Gu,Jingwei Sun,Weicheng Chen,Yanyan Qian,Xiaojing Ma,Weili Yan,Zhenshan Zhao,Ziqing Xu,Meijiao Suo,Wei Sheng,Guoying Huang

DOI: https://doi.org/10.3892/mmr.2022.12609

IF: 3.423

2022-01-01

Molecular Medicine Reports

Abstract:Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart malformation accounting for similar to 10% of cases. Although the pathogenesis of TOF is complex and largely unknown, epigenetics plays a huge role, specifically DNA methylation. The protein delta like non-canonical Notch ligand 1 (DLK1) gene encodes a non-canonical ligand of the Notch signaling pathway, which is involved in heart development. However, the epigenetic mechanism of DLK1 in the pathogenesis of TOF is yet to be elucidated. Therefore, the present study aimed to clarify its specific mechanism. In this study, immunohistochemistry was used to detect the protein expression of DLK1 and the methylation status of the DLK1 promoter was measured via bisulfite sequencing PCR. Dual-luciferase reporter assays were performed to examine the influence of transcription factor ETS proto-oncogene 1 (ETS1) on DLK1 gene expression. The electrophoretic mobility shift assay and chromatin immunoprecipitation assay, both in vivo and in vitro, were used to verify the binding of the ETS1 transcription factor to the DLK1 promoter as well as the influence of methylation status of DLK1 promoter on this binding affinity. The expression of DLK1 in the right ventricular outflow tract was significantly lower in patients with Tetralogy of Fallot (TOF) than that in controls (P<0.001). Moreover, the methylation level of CpG site 10 and CpG site 11 in the DLK1_R region was significantly decreased in TOF cases compared with controls (P<0.01). The integral methylation levels of DLK1_R and the methylation status of the CpG site 11 were both positively associated with DLK1 protein expression in TOF cases. ETS1 was found to inhibit DLK1 transcriptional activity by binding to the CpG site 11 and this affinity could be influenced by the methylation level of the DLK1 promoter. These findings demonstrated that the hypomethylation of the DLK1 promoter could increase the binding affinity of ETS1 transcription factor, which in turn inhibited DLK1 gene transcriptional activity and contributed to the development of TOF.
LINE-1 methylation status and its association with tetralogy of fallot in infants

Wei Sheng,Huijun Wang,Xiaojing Ma,Yanyan Qian,Ping Zhang,Yao Wu,Fengyun Zheng,Long Chen,Guoying Huang,Duan Ma

DOI: https://doi.org/10.1186/1755-8794-5-20

2012-01-01

BMC Medical Genomics

Abstract:Background Methylation levels of long interspersed nucleotide elements (LINE-1) are representative of genome-wide methylation status and play an important role in maintaining genomic stability and gene expression. To derive insight into the association between genome-wide methylation status and tetralogy of fallot (TOF), we compared the methylation status of LINE-1 element between TOF patients and controls. The methylation of the NKX 2 – 5, HAND 1, and TBX 20 promoter regions was also evaluated. Methods Genomic DNA from right ventricular tissue samples was obtained from 32 patients with TOF and 15 control subjects. Sequenom MassARRAY platform was performed to examine the methylation levels of LINE-1, NKX 2-5, HAND 1 and TBX 20. Mann–Whitney U test was used to compare differences in methylation levels between two groups. Results The methylation level of LINE-1 was significantly lower in patients with TOF, with a median of 57.95% (interquartile range [IQR]: 56.10%–60.04%), as opposed to 59.70% in controls (IQR: 59.00%–61.30%; P = 0.0021). The highest LINE-1 methylation level was 61.3%. The risk of TOF increased in subjects with the lowest methylation levels (less than or equal to 59.0%; OR = 14.7, 95% CI: 1.8–117.7, P = 0.014) and in those with medium methylation levels (59.0%–61.3%; OR = 2.0, 95% CI: 0.3–14.2, P = 0.65). An ROC curve analysis showed a relatively high accuracy of using the LINE-1 methylation level in predicting the presence of TOF (AUC = 0.78, 95% CI: 0.65–0.91; P = 0.002). The association of the LINE-1 methylation level with TOF was only observed in males ( P = 0.006) and not in females ( P = 0.25). Neither age nor gender was found to be associated with the LINE-1 methylation level in patients or controls. Higher methylation levels of NKX 2-5 and HAND 1 and lower methylation levels of TBX 20 were also observed in patients with TOF than in controls. No association was found between the methylation levels of NKX 2-5, HAND 1 and TBX 20 with the LINE-1 methylation level. Conclusions Lower LINE-1 methylation levels are associated with increased risk of TOF and may provide important clues for the development of TOF.
Association of Promoter Methylation Statuses of Congenital Heart Defect Candidate Genes with Tetralogy of Fallot

Wei Sheng,Yanyan Qian,Ping Zhang,Yao Wu,Huijun Wang,Xiaojing Ma,Long Chen,Duan Ma,Guoying Huang

DOI: https://doi.org/10.1186/1479-5876-12-31

IF: 8.44

2014-01-01

Journal of Translational Medicine

Abstract:Background: Although a lower methylation level of whole genome has been demonstrated in Tetralogy of Fallot (TOF) patients, little is known regarding changes in specific gene DNA methylation profiles and the possible associations with TOF. In current study, the promoter methylation statuses of congenital heart defect (CHD) candidate genes were measured in order to further understand epigenetic mechanisms that may play a role in the development of TOF.Methods: The methylation levels of CHD candidate genes were measured using the Sequenom MassARRAY platform. QRT-PCR was used to analyze the mRNA levels of CHD candidate genes in the right ventricular myocardium of TOF cases and normal controls.Results: Methylation status analysis was performed on the promoter regions of 71 CHD candidate genes (113 amplicons). We found significant differences in methylation status, between TOF cases and controls, in 26 amplicons (26 genes) (p < 0.05). Of the 26 amplicons, 17 were up regulated and 9 were down regulated. Additionally, 14 of them were located in the CpG islands, 7 were located in the CpG island shores, and 5 were covering the regions near the transcription start site (TSS). The methylation status was subsequently confirmed and mRNA levels were measured for 7 represented candidate genes, including EGFR, EVC2, NFATC2, NR2F2, TBX5, CFC1B and GJA5. The methylation values of EGFR, EVC2, TBX5 and CFC1B were significantly correlated with their mRNA levels (p < 0.05).Conclusions: Aberrant promoter methylation statuses of CHD candidate genes presented in TOF cases may contribute to the TOF development and have potential prognostic and therapeutic significance for TOF disease.
DNA Methylation at CpG Island Shore and RXRα Regulate NR2F2 in Heart Tissues of Tetralogy of Fallot Patients.

Li Xiaodi,Ye Ming,Xu Hongfei,Zhu Yanjie,Gu Ruoyi,Xiaojing Ma,Sheng Wei,Huang Guoying

DOI: https://doi.org/10.1016/j.bbrc.2020.06.110

IF: 3.1

2020-01-01

Biochemical and Biophysical Research Communications

Abstract:The nuclear receptor subfamily 2 group F member 2 (NR2F2) gene encodes a ligand-inducible transcription factor involved in angiogenesis and heart development. This study aimed to elucidate the molecular mechanism of epigenetic regulation of NR2F2 in tetralogy of Fallot (TOF) development. In the present study, immunohistochemical staining showed that NR2F2 protein expression was significantly higher in the right ventricular outflow tract (RVOT) tissues of TOF cases compared with controls. The methylation status of the CpG island shore (CGIS) of the NR2F2 gene was decreased in TOF cases, and the CpG site 3 in the CGIS region of NR2F2 promoter was a differential methylation site. Furthermore, the methylation level of the CpG site 3 and the NR2F2 protein expression were significantly negatively correlated in TOF patients. In vitro functional analysis revealed that RXR alpha could upregulate the NR2F2 gene by directly binding to the CGIS in the NR2F2 promoter, while hypomethylation of the NR2F2 promoter via treatment with 5-azacytidine influenced the affinity of RXRa to its binding sites, as shown by ChIP-qPCR. These findings suggest that promoter hypomethylation activates NR2F2 by enhancing RXR alpha binding to NR2F2 CGIS in the development of TOF. (C) 2020 Published by Elsevier Inc.
Methylation Status of CpG Sites in the NOTCH4 Promoter Region Regulates NOTCH4 Expression in Patients with Tetralogy of Fallot.

Yanjie Zhu,Ming Ye,Hongfei Xu,Ruoyi Gu,Xiaojing Ma,Mingwu Chen,Xiaodi Li,Wei Sheng,Guoying Huang

DOI: https://doi.org/10.3892/mmr.2020.11535

IF: 3.423

2020-01-01

Molecular Medicine Reports

Abstract:Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease (CHD). Although a lower methylation level of whole genome has been demonstrated in TOF patients, little is known regarding the DNA methylation changes in specific gene and its associations with TOF development. NOTCH4 is a mediator of the Notch signalling pathway that plays an important role in normal cardiac development. However, the role of epigenetic regulation of theNOTCH4gene in the pathogenesis of TOF remains unclear. Considering theNOTCH4low mutation frequency and reduced expression in the TOF patients, we hypothesized that abnormal DNA methylation change ofNOTCH4gene may influence its expression and responsible for TOF development. In this study, we measured the promoter methylation status ofNOTCH4and was measured and its regulation mechanism was explored, which may be related to TOF disease. Additionally, the promoter methylation statuses ofNOTCH4was measured in order to further understand epigenetic mechanisms that may serve a role in the development of TOF. Immunohistochemical analysis was used to examine NOTCH4 expression in right ventricular outflow tract myocardial tissues in patients with TOF. Compared with healthy controls, patients with TOF displayed significantly reduced in NOTCH4 expression (P=0.0055). Moreover, bisulphite sequencing suggested that the methylation levels of CpG site 2 in theNOTCH4promoter was significantly higher in the patients than in the controls (P=0.0459). NOTCH4 expression was negatively associated with CpG site 2 methylation levels (r=-0.51; P=0.01). ETS1 transcription factor can serve as transcriptional activators by binding to specific DNA sequences of target genes, such asDLL4andNOTCH4, which serves an important role in normal heart development. Dual-luciferase reporter and electrophoretic mobility shift assays indicated that the ETS1 transcription factor could bind to theNOTCH4promoter region. However, binding of ETS1 to theNOTCH4promoter was abrogated by methylation at the putative ETS1 binding sites. These findings suggested that decreased NOTCH4 expression in patients with TOF may be associated with hypermethylation of CpG site 2 in theNOTCH4promoter region, due to impaired binding of ETS1.
DNA methylation status of TBX20 in patients with tetralogy of Fallot

Juan Gong,Wei Sheng,Duan Ma,Guoying Huang,Fang Liu

DOI: https://doi.org/10.1186/s12920-019-0534-3

2019-01-01

BMC Medical Genomics

Abstract:Background TBX20 plays an important role in heart development; however, its epigenetic regulation in the pathogenesis of tetralogy of Fallot (TOF) remains unclear. Methods The methylation levels of the TBX20 promoter region in the right ventricular myocardial tissues of TOF and control samples were measured by the Sequenom MassARRAY platform. Bisulphite-sequencing PCR (BSP) was used to confirm the TBX20 methylation of CpG sites in cells. Dual-luciferase reporter assays were performed to detect the influence of TBX20 methylation and Sp1 transcription factors on gene activity. An electrophoretic mobility shift assay (EMSA) was used to explore the binding of the Sp1 transcription factor to the TBX20 promoter. Results TOF cases had a significantly lower TBX20 _M1 methylation level than controls (median methylation: 20.40% vs. 38.73%; p = 0.0047). The Sp1 transcription factor, which binds to Sp1 binding sites in the TBX20 _M1 region and promotes TBX20 gene activity, was blocked by the methylation of Sp1 binding sites in normal controls. With decreasing methylation in the TOF cases, the Sp1 transcription factor can bind to its binding site within the TBX20 promoter M1 region and promote TBX20 gene expression. Conclusions Hypomethylation of the TBX20 promoter region was observed in the TOF cases, and the high expression of the TBX20 gene may be caused by activated Sp1 transcription factor binding because of the decreasing methylation at the Sp1 transcription factor binding sites within TBX20_M1.
[Histone Acetylation and Expression of Acetylation-Related Enzymes in Children with Tetralogy of Fallot].

Jun Xu,Yi-Xiang Lin,Ruo-Yi Gu,Hui-Jun Wang,Xiao-Jing Ma,Duan Ma,Guo-Ying Huang

DOI: https://doi.org/10.7499/j.issn.1008-8830.2013.10.003

2013-01-01

Abstract:OBJECTIVE:To study the expression of histone acetyltransferases (HATs) and histone deacetylases (HDACs) in children with tetralogy of Fallot (TOF), and to investigate the role of histone acetylation and acetylation-related enzymes in the pathogenesis of TOF.METHODS:Myocardial tissue samples in the TOF group were obtained from 46 children with TOF who underwent radical operation, and myocardial tissue samples in the control group were obtained from 16 children who suffered accidental deaths and had no cardiac anomalies as shown by autopsy. The acetylation of H3K9, H3K18 and H3K27 was evaluated by immunohistochemistry. The mRNA expression of HATs and HDACs in the myocardium was measured by real-time PCR. The correlation between mRNA expression of HATs and HDACs and histone acetylation was analyzed.RESULTS:Compared with the control group, the TOF group showed significantly increased acetylation of H3K9 (P=0.0165) and significantly decreased acetylation of H3K18 (P=0.0048) and H3K27 (P=0.0084). As to 4 HATs and 6 HDACs, the mRNA expression of EP300 and CBP was significantly higher in the TOF group than in the control group (P=0.025; P=0.017), and there was no significant difference in the mRNA expression of other HATs and HDACs between the two groups. The correlation analysis revealed a positive correlation between H3K9 acetylation and mRNA expression of EP300 (r=0.71, P<0.01) and CBP (r=0.72, P<0.01).CONCLUSIONS:Upregulated mRNA expression of EP300 and CBP may be associated with increased H3K9 acetylation, suggesting that EP300 and CBP might affect cardiac development by regulating H3K9 acetylation.
Association Between Mrna Levels Of Dnmt1, Dnmt3a, Dnmt3b, Mbd2 And Line-1 Methylation Status In Infants With Tetralogy Of Fallot

Wei Sheng,Yanyan Qian,Huijun Wang,Xiaojing Ma,Ping Zhang,Long Chen,Duan Ma,Guoying Huang

DOI: https://doi.org/10.3892/ijmm.2013.1427

IF: 5.314

2013-01-01

International Journal of Molecular Medicine

Abstract:DNA methylation is catalyzed and maintained by DNA methyltransferases (DNMTs: DNMT1, DNMT3A and DNMT3B) and methyl-CpG-binding domain protein 2 (MBD2). However, little is known about the biological and clinical significance of the expression changes of DNMTs and MBD2 and their association with the methylation levels of long interspersed nuclear element-1 (LINE-1) in patients with tetralogy of Fallot (TOF). In this study, quantitative RT-PCR (qRT-PCR) was applied to analyze the mRNA levels of DNMTs and MBD2. The methylation status of LINE-1 was measured using the sequenom MassARRAY platform. The mRNA levels of the DNMTs and MBD2 showed a statistically significant decrease in the patients with TOF (P<0.001). The results also showed that patients with TOF had significantly lower global DNA methylation levels with a median of 61.50% [interquartile range (IQR), 59.78-63.77] compared with 63.54% (IQR, 62.49-64.88) among the controls (P=0.0099). In the controls, only DNMT1 showed a significant positive correlation with the DNMT3A mRNA levels (r=0.718, P=0.002). Of note, the DNMT1, DNMT3A, DNMT3B and MBD2 mRNA levels positively correlated with each other; this was statistically significant (P<0.05). A significant positive correlation with the global DNA methylation status was observed only for MBD2 (r=-0.579, P=0.005) in patients with TOF. In conclusion, lower LINE-1 methylation levels significantly correlate with aberrant MBD2 mRNA levels. The lower expression of DNMT1 and DNMT3B may play an important role in the pathogenesis of TOF.
HAND1 Loss-of-Function Mutation Causes Tetralogy of Fallot.

Juan Wang,Xiao-Qing Hu,Yu-Han Guo,Jian-Yun Gu,Jia-Hong Xu,Yan-Jie Li,Ning Li,Xiao-Xiao Yang,Yi-Qing Yang

DOI: https://doi.org/10.1007/s00246-016-1547-8

2016-01-01

Pediatric Cardiology

Abstract:As the most prevalent form of birth defect in humans worldwide, congenital heart disease (CHD) is responsible for substantial morbidity and is still the leading cause of birth defect-related demises. Increasing evidence demonstrates that genetic defects play an important role in the pathogenesis of CHD, and mutations in multiple genes, especially in those coding for cardiac core transcription factors, have been causally linked to various CHDs. Nevertheless, CHD is a genetically heterogeneous disease and the genetic determinants underpinning CHD in an overwhelming majority of patients remain elusive. In the current study, genomic DNA was extracted from venous blood samples of 165 unrelated patients with CHD, and the coding exons and splicing junction sites of the HAND1 gene, which encodes a basic helix-loop-helix transcription factor essential for cardiovascular development, were sequenced. As a result, a novel heterozygous mutation, p.R118C, was identified in a patient with tetralogy of Fallot (TOF). The missense mutation, which was absent in 600 referential chromosomes, altered the amino acid that was completely conserved evolutionarily. Biological assays with a dual-luciferase reporter assay system revealed that the R118C-mutant HAND1 protein had significantly reduced transcriptional activity when compared with its wild-type counterpart. Furthermore, the mutation significantly decreased the synergistic activation of a downstream target gene between HAND1 and GATA4, another cardiac core transcription factor associated with TOF. To our knowledge, this is the first report on the association of a HAND1 loss-of-function mutation with enhanced susceptibility to TOF in humans. The findings provide novel insight into the molecular etiology underlying TOF, suggesting potential implications for the improved prophylactic and therapeutic strategies for TOF.
Identification of miRNA–mRNA–TFs Regulatory Network and Crucial Pathways Involved in Tetralogy of Fallot

Guoling You,Bailing Zu,Bo Wang,Qihua Fu,Fen Li

DOI: https://doi.org/10.3389/fgene.2020.00552

IF: 3.7

2020-06-12

Frontiers in Genetics

Abstract:Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart disease. However, its pathogenesis remains unknown. To explore key regulatory connections and crucial pathways underlying the TOF, gene or microRNA expression profile datasets of human TOF were obtained from the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database. The differentially expressed mRNAs (DEmRNAs) and microRNAs (DEmiRs) between TOF and healthy groups were identified after data preprocessing, followed by Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. Then, we further constructed protein–protein interaction (PPI) network and subnetwork of modules. Ultimately, to investigate the regulatory network underlying TOF, a global triple network including miRNAs, mRNAs, and transcription factors (TFs) was constructed based on the integrated data. In the present study, a total of 529 DEmRNAs, including 115 downregulated and 414 upregulated DEmRNAs, and 7 significantly upregulated DemiRs, including miR-499, miR-23b, miR-222, miR-1275, miR-93, miR-155, and miR-187, were found between TOF and control groups. Furthermore, 22 hub genes ranked by top 5% genes with high connectivity and six TFs, including SRF, CNOT4, SIX6, SRRM3, NELFA, and ONECUT3, were identified and might play crucial roles in the molecular pathogenesis of TOF. Additionally, an miRNA–mRNA–TF co-regulatory network was established and indicated ubiquitin-mediated proteolysis, energy metabolism associated pathways, neurodevelopmental disorder associated pathways, and ribosomes might be involved in the pathogenesis of TOF. The current research provides a comprehensive perspective of regulatory mechanism networks underlying TOF and also identifies potential molecule targets of genetic counseling and prenatal diagnosis for TOF.

genetics & heredity
Promoter Methylation and Expression of the VANGL2 Gene in the Myocardium of Pediatric Patients with Tetralogy of Fallot

Yuan,Yan Gao,Huijun Wang,Xiaojing Ma,Duan Ma,Guoying Huang

DOI: https://doi.org/10.1002/bdra.23291

2014-01-01

Abstract:BACKGROUND:Tetralogy of Fallot (ToF) is the most common form of cyanotic congenital heart disease and is a major cause of significant morbidity and mortality. VANGL2 is a critical gene in the planar cell polarity pathway that plays an important role in the development of the heart. This study investigates the methylation status of the promoter region of VANGL2 and the expression pattern of VANGL2 in cardiac tissue.METHODS:The promoter region of VANGL2 was sequenced in 200 ToF patients and 400 control subjects. Methylation levels were measured in four regions of the VANGL2 promoter (B1-1: -282 bp ∼ -117 bp, B1-2: -117 bp ∼ 41 bp, B2: 8 bp ∼ 157 bp, B3: 132 bp ∼ 401 bp) by bisulfite sequencing PCR in the right ventricular outflow tract of the myocardium. Quantitative real-time PCR and immunohistochemistry were used to detect the mRNA and protein expression levels, respectively.RESULTS:No mutations were found in the promoter region, but two SNPs (rs11582932 T>G, rs11265385 T>G) were found in ToF patients and controls with similar frequencies (p>0.05). The overall methylation status of the VANGL2 promoter was significantly higher in ToF patients than in controls (p=0.0234). Specifically, the methylation levels of regions B1-1 and B3 were significantly higher in ToF patients (p=0.0042, p=0.0418). Both the VANGL2 mRNA and protein levels were significantly lower in ToF patients than in controls (p<0.05).CONCLUSION:The aberrant VANGL2 promoter methylation and the decreased gene expression in ToF patients may provide important clues for the development of ToF.
Hypermethylation-mediated down-regulation of lncRNA TBX5-AS1:2 in Tetralogy of Fallot inhibits cell proliferation by reducing TBX5 expression.

Jing Ma,Shiyu Chen,Lili Hao,Wei Sheng,WeiCheng Chen,Xiaojing Ma,Bowen Zhang,Duan Ma,Guoying Huang

DOI: https://doi.org/10.1111/jcmm.15298

2020-01-01

Journal of Cellular and Molecular Medicine

Abstract:Tetralogy of Fallot (TOF) is the most common complex congenital heart disease (CHD) with uncertain cause. Although long non-coding RNAs (lncRNAs) have been implicated in heart development and several CHDs, their role in TOF is not well understood. This study aimed to investigate how dysregulated lncRNAs contribute to TOF. Using Gene Expression Omnibus data mining, bioinformatics analysis and clinical heart tissue sample detecting, we identified a novel antisense lncRNA TBX5-AS1:2 with unknown function that was significantly down-regulated in injured cardiac tissues from TOF patients. LncRNA TBX5-AS1:2 was mainly located in the nucleus of the human embryonic kidney 293 (HEK293T) cells and formed an RNA-RNA double-stranded structure in the overlapping region with its sense mRNA T-box transcription factor 5 (TBX5), which is an important regulator in heart development. Knock-down of lncRNA TBX5-AS1:2 via promoter hypermethylation reduced TBX5 expression at both the mRNA and protein levels by affecting its mRNA stability through RNA-RNA interaction. Moreover, lncRNA TBX5-AS1:2 knock-down inhibited the proliferation of HEK293T cells. In conclusion, these results indicated that lncRNA TBX5-AS1:2 may be involved in TOF by affecting cell proliferation by targeting TBX5.
The CpG Island Methylation Status Analysis in the Promoter Region of the Conotruncal Heart Malformation Candidate Gene NKX2-5

Sheng Wei,Wang Hui-jun,Ma Xiao-jing,Li Wen-can,Chen Long,Zhang Jin,Huang Guo-ying,Ma Duan

DOI: https://doi.org/10.3969/j.issn.1674-7399.2010.03.004

2010-01-01

Abstract:Objective To study the promoter methylation status of heart tissue-specific transcription factor NKX2-5 gene between congenital heart conotruncal defects (CTD) and normal fetal cardiac tissue samples,and to investigate the pathogenesis of congenital heart disease from the epigenetic point of view. Methods First,the genome DNA fragments were generated by the Tru1l restriction enzyme and then connected to the adaptor. The methylated DNA fragments were enriched by the methylated binding protein (MBD),which can specifically bind and interact with methyl-CpG island. Finally,the CpG island methylation status in the promoter region of NKX2-5 gene was detected by Real Time PCR.Results In 6 CTD cases we detected,4 showed hypermethylation status in NKX2-5 gene promoter,compared with normal fetal heart tissue.Conclusion NKX2-5 gene hypermethylation might be one of molecular marker of congenital heart disease.
Search of Somatic Mutations of NKX2-5 and GATA4 Genes in Chinese Patients with Sporadic Congenital Heart Disease

Jie Yin,Jianhua Qian,Genyin Dai,Chunli Wang,Yuming Qin,Ting Xu,Zewei Li,Han Zhang,Shiwei Yang

DOI: https://doi.org/10.1007/s00246-018-1955-z

2018-01-01

Pediatric Cardiology

Abstract:Congenital heart disease (CHD) usually occurs sporadically, with only a minority of cases associated with a known genetic mechanism. Cardiac-specific transcription factors NKX2-5 and GATA4 play key roles in the mammalian heart development, and the affected cardiac tissues of CHD patients are prone to somatic mutations which thus participate in the pathogenesis of CHD. We collected 98 patients with sporadic CHD, extracted genomic DNA from cardiac tissues and blood, and then screened NKX2-5 and GATA4 genes using PCR-direct sequence analysis. A novel heterozygous missense mutation (c.907G > A, p.V303I) of NKX2-5 gene was identified in a patient with tetralogy of Fallots. Functional assay revealed that this mutant was associated with significantly reduced transcriptional activity. In addition, we found two known single-nucleotide polymorphisms (SNPs) (rs2277923, rs3729753) in NKX2-5 and two known SNPs (rs56166237, rs3729856) in GATA4. All variations identified in cardiac tissues were consistent with those of peripheral blood, and no somatic mutations were found in cardiac tissues. Our study shows no evidence of NKX2-5 and GATA4 somatic mutations playing a role in the pathogenesis of sporadic CHD.
CpG island shore methylation of ZFPM2 is identified in tetralogy of fallot samples

Wei Sheng,Long Chen,Huijun Wang,Xiaojing Ma,Duan Ma,Guoying Huang

DOI: https://doi.org/10.1038/pr.2016.42

IF: 3.953

2016-01-01

Pediatric Research

Abstract:Background: ZFPM2 gene plays an important role in heart morphogenesis and development of coronary vessels from epicardium, however, little is known regarding its epigenetic regulation in the pathogenesis of tetralogy of fallot (TOF). Methods: The methylation levels of ZFPM2 gene were measured by MassArray (Sequenom, San Diego, CA) and bisulfite sequencing polymerase chain reaction (PCR) (BSP). Real-time PCR was performed to analyze the mRNA levels for ZFPM2 gene in the myocardium of TOF. Results: The methylation levels in the CpG island shore of ZFPM2 promoter were significantly higher in patients with TOF, with a median of 80.32% (interquartile range (IQR): 73.54–85.75%, N = 42), as compared to 59.63% in controls (IQR: 44.79–73.83%; P = 0.0186, N = 6). No significant difference was observed in the methylation status at the CpG island of ZFPM2 promoter. The ZFPM2 mRNA levels were significantly lower in patients with TOF compared to that in the controls ( P < 0.05). The aberrant methylation values of ZFPM2 were negatively associated with significant changes in its mRNA level ( r = −0.40, P = 0.008, N = 42). Conclusion: Aberrant methylation status at the promoter CpG island shore of ZFPM2 gene may be associated with its gene transcription regulation in the TOF patients.
Whole-exome sequencing revealed novel genetic alterations in patients with tetralogy of Fallot

Yu Pan,Manli Liu,Songsong Zhang,Huaxian Mei,Jing Wu

DOI: https://doi.org/10.21037/tp-23-449

2023-10-30

Abstract:Background: The most prevalent cyanotic congenital heart disease (CHD) phenotype is tetralogy of Fallot (TOF). Rare genetic variations have been identified as significant risk factors for CHD. Thus, this research sought to identify the pathogenic variations and molecular etiologies of TOF. Methods: This study employed whole-exome sequencing (WES) and Sanger sequencing to identify pathogenic variations in DNA samples from patients with TOF. The pathogenicity of the variations was predicted using an in-silico approach. Results: We enrolled 17 patients with TOF in this study. Among these patients, 14 had mutations in TOF-related genes, including GJB2, TBX15, CTNS, SPINK1, GATA6, PRIMOL, GDF15, SLC17A9, AIFM1, FOXC2, KLF13, ABCA4, CPA6, FKBP10, ASPA, SBF1, HBA2, IGLL1, GNE, and KLHL10. We also gathered WES data from three participants without TOF, who comprised the control group, but no variations were found in the indicated genes. Further analysis showed that the patients with FKBP10 and GNE variants had more serious clinical symptoms. Sanger sequencing confirmed that the two variants were heterozygous in TOF patients. Conclusions: We identified several genetic variants associated with TOF and confirmed that FKBP10 and GNE variants were associated with TOF severity. The findings of this study help researchers and clinicians on genetic counseling with the verification of the potential of WES in detecting TOF and help implement early interventions for patients with TOF.
Somatic GATA4 mutation contributes to tetralogy of Fallot

Pradhan Abhinav,Yan-Jie Li,Ri-Tai Huang,Xing-Yuan Liu,Jia-Ning Gu,Chen-Xi Yang,Ying-Jia Xu,Juan Wang,Yi-Qing Yang

DOI: https://doi.org/10.3892/etm.2024.12379

IF: 2.7

2024-01-08

Experimental and Therapeutic Medicine

Abstract:Tetralogy of Fallot (TOF) is the most prevalent cyanotic congenital heart pathology and causes infant morbidity and mortality worldwide. GATA-binding protein 4 (GATA4) serves as a pivotal transcriptional factor for embryonic cardiogenesis and germline GATA4 mutations are causally linked to TOF. However, the effects of somatic GATA4 mutations on the pathogenesis of TOF remain to be ascertained. In the present study, sequencing assay of GATA4 was performed utilizing genomic DNA derived from resected heart tissue specimens as well as matched peripheral blood specimens of 62 patients with non-familial TOF who underwent surgical treatment for TOF. Sequencing of GATA4 was also performed using the heart tissue specimens as well as matched peripheral venous blood samples of 68 sporadic cases who underwent heart valve displacement because of rheumatic heart disorder and the peripheral venous whole blood samples of 216 healthy subjects. The function of the mutant was explored by dual-luciferase activity analysis. Consequently, a new GATA4 mutation, NM_002052.5:c.708T>G;p.(Tyr236*), was found in the heart tissue of one patient with TOF. No mutation was detected in the heart tissue of the 68 cases suffering from rheumatic heart disorder or in the venous blood samples of all 346 individuals. GATA4 mutant failed to transactivate its target gene, myosin heavy chain 6. Additionally, this mutation nullified the synergistic transactivation between GATA4 and T-box transcription factor 5 or NK2 homeobox 5, two genes causative for TOF. Somatic GATA4 mutation predisposes TOF, highlighting the significant contribution of somatic variations to the molecular pathogenesis underpinning TOF.

medicine, research & experimental
Abstract MP245: Tet Proteins Regulate Second Heart Field Multipotent Progenitors Differentiating To Myocytes

Shaohai Fang,Jia Li,Jeff D Steimle,Lei Guo,Yuhan Yang,Tingting Hong,Rui Wang,Wei Han,Yubin Zhou,Jun Wang,James F Martin,Yun Huang

DOI: https://doi.org/10.1161/res.129.suppl_1.mp245

IF: 23.213

2021-09-03

Circulation Research

Abstract:DNA methylation and demethylation play an important role in shaping the epigenetic landscape and chromatin accessibility to control gene expression during development in mammals. Ten-eleven Translocation (Tet1, Tet2 and Tet3) is a family of dioxygenases that catalyze DNA methylation oxidation with ultimate DNA demethylation. Our previous study showed that cardiac-specific deletion of Tet2 and Tet3 could disrupt YY1-mediated long range chromatin interactions during heart development and lead to ventricular non-compaction cardiomyopathy. However, it is still unclear whether and how Tet protein mediated epigenetic modifications contribute to cardiac lineage specification during embryonic development. In this study, we generated cardiac specific Tet1-3 triple deficient (Tet-TKO) mouse lines using various cardiac specific Cres to evaluate the function of Tet protein in regulating cardiac lineage specification. We observed developmental defects at outflow tract (OFT) in Tet-TKO embryos, suggesting that Tet deficiency affects the second heart field (SHF) development. Single cell RNA-seq analysis further revealed the accumulation of multipotent SHF progenitors and subsequent halt of myocyte differentiation upon Tet depletion. At the molecular level, we found that Tet ablation perturbs the transcriptional network of Islet1, a transcription factor that is crucial for cardiac development in embryos. Overall, our study demonstrates a critical role of Tet-mediated epigenetic regulation for embryonic cardiac development.

cardiac & cardiovascular systems,peripheral vascular disease,hematology
Downregulated Nuclear Lncrna NRON Inhibits SHP2/Wnt/β-catenin Signaling and Cardiomyocyte Differentiation During the Development of Tetralogy of Fallot

Hui Zhang,Lei Lu,Chao Li,Hongdou Li,Jie Tian,Hongyan Wang

DOI: https://doi.org/10.1016/j.gendis.2022.10.010

IF: 7.376

2023-01-01

Genes & Diseases

Abstract:Tetralogy of Fallot(TOF)is the most common cyanotic congenital heart disease and the incidence of late cardiac death in long-term survivors continues to increase.

DNA Methylation Status of NKX2-5, GATA4 and HAND1in Patients with Tetralogy of Fallot

NEXN Inhibits GATA4 and Leads to Atrial Septal Defects in Mice and Humans

CpG Site Hypomethylation at ETS1‑binding Region Regulates DLK1 Expression in Chinese Patients with Tetralogy of Fallot.

LINE-1 methylation status and its association with tetralogy of fallot in infants

Association of Promoter Methylation Statuses of Congenital Heart Defect Candidate Genes with Tetralogy of Fallot

DNA Methylation at CpG Island Shore and RXRα Regulate NR2F2 in Heart Tissues of Tetralogy of Fallot Patients.

Methylation Status of CpG Sites in the NOTCH4 Promoter Region Regulates NOTCH4 Expression in Patients with Tetralogy of Fallot.

DNA methylation status of TBX20 in patients with tetralogy of Fallot

[Histone Acetylation and Expression of Acetylation-Related Enzymes in Children with Tetralogy of Fallot].

Association Between Mrna Levels Of Dnmt1, Dnmt3a, Dnmt3b, Mbd2 And Line-1 Methylation Status In Infants With Tetralogy Of Fallot

HAND1 Loss-of-Function Mutation Causes Tetralogy of Fallot.

Identification of miRNA–mRNA–TFs Regulatory Network and Crucial Pathways Involved in Tetralogy of Fallot

Promoter Methylation and Expression of the VANGL2 Gene in the Myocardium of Pediatric Patients with Tetralogy of Fallot

Hypermethylation-mediated down-regulation of lncRNA TBX5-AS1:2 in Tetralogy of Fallot inhibits cell proliferation by reducing TBX5 expression.

The CpG Island Methylation Status Analysis in the Promoter Region of the Conotruncal Heart Malformation Candidate Gene NKX2-5

Search of Somatic Mutations of NKX2-5 and GATA4 Genes in Chinese Patients with Sporadic Congenital Heart Disease

CpG island shore methylation of ZFPM2 is identified in tetralogy of fallot samples

Whole-exome sequencing revealed novel genetic alterations in patients with tetralogy of Fallot

Somatic GATA4 mutation contributes to tetralogy of Fallot

Abstract MP245: Tet Proteins Regulate Second Heart Field Multipotent Progenitors Differentiating To Myocytes

Downregulated Nuclear Lncrna NRON Inhibits SHP2/Wnt/β-catenin Signaling and Cardiomyocyte Differentiation During the Development of Tetralogy of Fallot